Menu

News & Insights

  • Clear

AG Marshall Leads Coalition Alerting National Security Council to China Supply Chain Exploitation of FDA-Approved Drugs

Alabama AG Steve Marshall led a coalition of 20 state AGs in sending a letter to Secretary of State Marco Rubio raising national security concerns about the pharmaceutical supply chain and the sourcing of dangerous ingredients used in compounded GLP-1 medications, including semaglutide, tirzepatide, and retatrutide. The letter cites that in September 2025, the Food…

Read More

Attorney General Brown Announces $13 Million in Settlements with Seven Opioid Drug Manufacturers

Maryland AG Anthony Brown has announced settlements with seven opioid drug manufacturers including Alvogen, Amneal, Apotex, Hikma, Mylan, Sun, and Zydus. Maryland is expected to receive over $13 million from the multistate settlement. The AGs alleged that for decades these seven companies have manufactured and sold generic opioids including oxycodone, hydrocodone, and fentanyl patches throughout the U.S., and that each of…

Read More

FTC Files Amicus Brief in Pharmaceutical Antitrust Case

The FTC has filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct. The brief argues that the Supreme Court precedent establishes that antitrust law is focused on the impact of anticompetitive conduct, not on the intent to harm competition. CareFirst of Maryland…

Read More